Skip to content
Stephen V Liu, MD· @StephenVLiu · X·· 2026-04-19Score60

KEAP1

Reading

KRAS / RAS targeting: from platform to Phase 3

Body

#AACR26 EFS prolonged with nivo regardless of ctDNA status (detectable at baseline, clearance before surgery, MRD status). Machine learning model associates EFS with ctDNA clearance, non-N2, squamous histology, and nivo treatment (but NOT KEAP1, SMARCA4, CDKN2A mt).

Heat 36 · 21 likes · 1 reply · 14 reposts

Source: Stephen V Liu, MD · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org